president trump glp 1 Donald announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 weight loss drugs Wegovy and Zepbound, a move that could make them more Trump's GLP-1 deals leaves questions
Description
A new study finds that GLP-1 medications are linked to lower overall cancer risk, particularly for endometrial and ovarian cancers, in obese adults
National Post reports generic semaglutide products could reach Canadian pharmacy shelves by summer 2026 as Health Canada reviews nine applications.
Achieve Your Weight Loss Goals with GLP-1 Injections
LOW CARB | KETO-FRIENDLY | GLUTEN-FREE | DIABETIC FRIENDLY
For higher or adjustable dosing options, please refer to our standard GLP-1 program
Conclusions GLP-1 agonists are associated with significant pancreatitis risk which increases with larger cumulative doses.
